Inclusion Criteria:  ages 9-17 meets Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) diagnostic criteria for TD or PTD at screening visit, a Parent Tic Questionnaire (PTQ) total score > 18 and < 60 OR > 12 and < 40 if persistent tic disorder (for total scores > 60 on the PTQ, the research team will examine the patient's global functioning to determine participation appropriateness. The research team will consider if other treatments, such as medication, may be more appropriate for participants with PTQ total scores > 60. If the participant is already taking tic medication, or tic medication has been unsuccessful in the past, then he/she may be considered for the study) at baseline visit, a Yale Global Tic Severity Score (YGTSS Total Score) > 14 and < 30 OR > 10 and < 20 if persistent tic disorder (for total scores > 30 on the YGTSS, the research team will examine the patient's global functioning to determine participation appropriateness) no history of behavioral treatment for tics, including self-guided therapy programs for tics unmedicated or on stable medication for tics and other psychiatric disorder for at least 6 weeks, with no planned changes during study participation access to a personal computer (desktop or laptop) with a camera access to an Internet connection with a minimum speed of 5 megabytes per second (Mbps) fluent English speaker.  Exclusion Criteria:  co-occurring disorders that require more immediate treatment or change to current treatment T-Score < 37 on the Wechsler Abbreviated Scale of Intelligence (WASI) - Vocabulary subtest T-Score > 70 on the inattention or hyperactivity/impulsivity scales of the Conners 3-Parent Short (C 3-PS).